The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan

Jui-Yao Liu, Tzeng-Ji Chen and Shinn-Jang Hwang
Additional contact information
Jui-Yao Liu: Department of Family Medicine, Taipei Veterans General Hospital, No.201, Sec. 2, Shi-Pai Road, Taipei 11217, Taiwan
Tzeng-Ji Chen: Department of Family Medicine, Taipei Veterans General Hospital, No.201, Sec. 2, Shi-Pai Road, Taipei 11217, Taiwan
Shinn-Jang Hwang: Department of Family Medicine, Taipei Veterans General Hospital, No.201, Sec. 2, Shi-Pai Road, Taipei 11217, Taiwan

IJERPH, 2016, vol. 13, issue 5, 1-6

Abstract: Menopausal hormone replacement therapy (HRT) increases the risk of breast cancer in Western countries; however, there are fewer reports from the Asian population, which has a lower incidence of breast cancer. A population-based retrospective cohort study was conducted by analyzing longitudinal National Health Insurance claim data of a 200,000-person national representative cohort. A total of 22,929 women aged ≥45 years in 1997 without previous diagnosis of breast cancer were enrolled and stratified into two birth cohorts born before or after 1933. HRT prescriptions were traced in outpatient data files and incident breast cancer cases were identified from 1997 to 2004. The Cox proportional hazards model was used to analyze breast cancer hazard ratio (HR). HRT users were censored after they discontinued HRT. The results showed that women born during 1933–1952 had a twofold increased risk of breast cancer (HR = 2.10, 95% CI = 1.47–3.00) compared with women born before 1933, when adjusted for HRT use. When adjusted for the birth-cohort difference, HRT users had significantly increased breast cancer HR versus non-users after four years of use (adjusted HR = 1.48, 95% CI = 1.03–2.13); the HR further increased to 1.95 (95% CI = 1.34–2.84) after eight years of use. In conclusion, a longer duration of current HRT use was associated with a higher risk of breast cancer independent of the birth-cohort difference.

Keywords: menopausal hormone replacement therapy; breast cancer; birth-cohort effect; National Health Insurance Research Database; Asian population (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/13/5/482/pdf (application/pdf)
https://www.mdpi.com/1660-4601/13/5/482/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:13:y:2016:i:5:p:482-:d:69803

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().